US Patent 11130744 Indenyl compounds, pharmaceutical compositions, and medical uses thereof
Patent 11130744 was granted and assigned to ADT Pharmaceuticals, LLC on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+76 characters)
Article
Patent abstract
Disclosed are compounds, for example, compounds of formula I,
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Adam B. Keeton0
Gary A. Piazza0
Michael R. Boyd0
Xi Chen0
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111307440
Date of Patent
September 28, 2021
0Patent Application Number
202003300
Date Filed
March 30, 2020
0Official Website
Patent Citations Received
Edits on 10 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11130744 Indenyl compounds, pharmaceutical compositions, and medical uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11130744
Date of patent
September 28, 2021
Patent application number
20200330
Date Filed
March 30, 2020
Find more entities like US Patent 11130744 Indenyl compounds, pharmaceutical compositions, and medical uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
